Regulatory Toxicology, Third Edition

Editor

Shayne C. Gad, BS (Whittier College, Chemistry and Biology, 1971) and PhD in Pharmacology/

Toxicology (Texas, 1977), DABT, is the principal of Gad Consulting Services, a twenty-five-yearold

consulting firm with nine employees and more than 500 clients (including 140 pharmaceutical

companies in the US and 50 overseas). Prior to this, he served in director-level and above positions at

Searle, Synergen, and Beckton Dickinson. He has published 50 books and more than 350 chapters,

articles, and abstracts in the fields of toxicology, statistics, pharmacology, drug development, and

safety assessment. He has more than 40 years of broad-based experience in toxicology, drug and

device development, statistics, and risk assessment. He has specific expertise in neurotoxicology,

in vitro methods, cardiovascular toxicology, inhalation toxicology, immunotoxicology, and genotoxicology.

Past president of the American College of Toxicology, the Roundtable of Toxicology

Consultants, and three of SOT's (Society of Toxicology) specialty sections. He has direct involvement

in the preparation of Investigational New Drug applications (INDs, 115 successfully to date), New

Drug Application (NDA), Product License Application (PLA), Abbreviated New Drug Application

(ANDA), 501(k), Investigational Device Exemption (IDE), Common Technical Document (CTD),

clinical data bases for phase 1 and 2 studies, and Premarket Approval Applications (PMAs). He has

consulted for the Food and Drug Administration (FDA), Environmental Protection Agency (EPA),

and National Institutes of Health (NIH), has trained reviewers, and has been an expert witness for

the FDA. He has also conducted the triennial toxicology salary survey as a service to the profession

for the last 29 years.

Dr. Gad is also a retired Navy officer with more than 26 years in service.